View of Cardiopulmonary Effects of Combined β1-Selective Blockers, Ivabradine, and β2-Agonists in the Ischemic Heart Disease with Chronic Obstructive Pulmonary Disease

Return to Article Details Cardiopulmonary Effects of Combined β1-Selective Blockers, Ivabradine, and β2-Agonists in the Ischemic Heart Disease with Chronic Obstructive Pulmonary Disease Download Download PDF